Related Experiment Video
Updated: May 14, 2026
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Reactive rifampicin derivative able to damage transcription complex
Maxim Kozlov1, Eugeny Nudler, Vadim Nikiforov
1PHRI Center and New Jersey Medical School, Department of Microbiology and Molecular Genetics, University of Medicine and Dentistry of New Jersey, 225 Warren Street, Newark, NJ 07103, USA.
Bioconjugate Chemistry
|February 22, 2013
Summary
We modified the antibiotic Rifampicin (Rif) to create an "aggressive" drug. This new compound effectively targets and cleaves bacterial RNA polymerase and DNA, offering a promising new strategy for treating tuberculosis (TB).
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Antimicrobial Drug Development
Background:
- Rifampicin (Rif) is a broad-spectrum antibiotic targeting bacterial RNA polymerase (RNAP).
- Enhancing antibiotic efficacy involves attaching active chemical groups for collateral damage.
- Dormant Mycobacterium tuberculosis strains are often resistant to conventional antibiotics.
Purpose of the Study:
- To enhance Rifampicin's efficacy by tethering it to a Fe(2+)-EDTA chelate.
- To investigate the collateral damage mechanism of the modified Rifampicin derivative.
- To explore its potential for treating drug-resistant tuberculosis.
Main Methods:
- Chemical synthesis of Rifampicin tethered to Fe(2+)-EDTA.
- Assessing the binding affinity of the modified drug to RNAP.
- Analyzing the cleavage sites on RNAP and promoter DNA.
Main Results:
- The synthesized Rif derivative maintained high RNAP binding affinity.
- Localized cleavage of RNAP and promoter DNA was observed.
- Specific cleavage of the RNAP β subunit and DNA near the transcription start site occurred.
Conclusions:
- The modified Rifampicin derivative acts as an "aggressive" drug, inducing localized DNA and RNAP cleavage.
- This approach shows potential for targeting dormant, drug-resistant Mycobacterium tuberculosis.
- The study exemplifies a novel strategy for developing enhanced antibiotics for tuberculosis treatment.
Related Concept Videos
01:23Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
01:20Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:23Transcriptional Regulation: Riboswitches
Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
02:42Transcription Attenuation in Prokaryotes
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...